FLD (NASDAQ: FLD) files Form 144 listing restricted stock vesting and resales

Rhea-AI Filing Summary

FLD filed a Form 144 reporting proposed resales of Common Stock tied to prior grants and routine transactions. The notice lists a Restricted Stock Vesting event on 05/01/2026 and multiple reported sales by Wolfe Repass on dates in February–April 2026 with per‑trade share counts and dollar amounts.

Insights

Securities Compliance Analyst

Rule 144 resale notice listing restricted stock vesting and multiple dated sales.

The filing records a Restricted Stock Vesting event effective 05/01/2026 and enumerates multiple sales by Wolfe Repass between 02/19/2026 and 04/20/2026, each showing shares and proceeds. This is a routine resale filing under Section 144 procedures.

Cash‑flow treatment to issuer or purchasers is not specified in the excerpt; timing and method of any future sales are governed by resale rules and the listed dates reflect transactions already reported.

Key Figures

Restricted Stock Vesting date: 05/01/2026 Sale example - 02/19/2026: 21,857 shares Proceeds example - 02/19/2026: $32,427.05 +4 more

7 metrics

Restricted Stock Vesting date 05/01/2026 Restricted Stock Vesting (Compensation)

Sale example - 02/19/2026 21,857 shares Wolfe Repass sale on 02/19/2026

Proceeds example - 02/19/2026 $32,427.05 Proceeds reported for 21,857 shares on 02/19/2026

Sale example - 02/26/2026 13,675 shares Wolfe Repass sale on 02/26/2026

Proceeds example - 02/26/2026 $20,006.53 Proceeds reported for 13,675 shares on 02/26/2026

Sale example - 03/02/2026 11,281 shares Wolfe Repass sale on 03/02/2026

Proceeds example - 03/02/2026 $16,052.86 Proceeds reported for 11,281 shares on 03/02/2026

Key Terms

Form 144, Restricted Stock Vesting, Compensation, Securities To Be Sold

4 terms

Form 144 regulatory

"filed a Form 144 reporting proposed resales of Common Stock"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Common | 05/01/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Compensation financial

"05/01/2026 | Compensation"

Securities To Be Sold regulatory

"144: Securities To Be Sold"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/04/2026 - 04:39 PM Learn about SEC filing dates

FAQ

What does FLD's Form 144 report mean for shareholders?

It reports proposed or recent resales of Common Stock, including a restricted stock vesting on 05/01/2026. The filing lists specific trade dates and share counts, indicating transfers by insiders or affiliates rather than operational or financial performance information.

How many shares did Wolfe Repass report selling in the filing for FLD?

The filing lists multiple individual sales by Wolfe Repass with per‑trade counts (for example, 21,857 on 02/19/2026 and 13,675 on 02/26/2026). It presents each trade's share count and dollar amount rather than an aggregate total.

Does the Form 144 show shares issued to employees at FLD?

Yes; it shows a Restricted Stock Vesting event dated 05/01/2026 listed as Compensation. That line identifies shares credited from an issuer compensation vesting rather than an open‑market purchase.

Are proceeds from the reported sales paid to FLD?

The excerpt does not state who received sale proceeds. The listed Wolfe Repass transactions show dollar amounts per trade, but the filing excerpt does not attribute proceeds to the issuer or selling holder.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1947	2768.64	49831298	05/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/01/2026	Restricted Stock Vesting	Issuer			1947	05/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Wolfe Repass 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	02/19/2026	21857	32427.05
Wolfe Repass 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	02/20/2026	12406	19179.67
Wolfe Repass 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	02/23/2026	4179	6192.86
Wolfe Repass 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	02/24/2026	13796	20285.64
Wolfe Repass 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	02/25/2026	5245	7958.76
Wolfe Repass 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	02/26/2026	13675	20006.53
Wolfe Repass 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	02/27/2026	9177	13575.54
Wolfe Repass 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	03/02/2026	11281	16052.86
Wolfe Repass 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	03/20/2026	176	219.35
Wolfe Repass 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	04/02/2026	1326	1620.11
Wolfe Repass 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	04/20/2026	236	354.12

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)